Article(id=1236369017783505623, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1236369011668210230, articleNumber=null, orderNo=null, doi=null, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=null, receivedDateStr=null, revisedDate=null, revisedDateStr=null, acceptedDate=1665417600000, acceptedDateStr=2022-10-11, onlineDate=1772702944464, onlineDateStr=2026-03-05, pubDate=1692028800000, pubDateStr=2023-08-15, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1772702944464, onlineIssueDateStr=2026-03-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1772702944464, creator=13701087609, updateTime=1772702944464, updator=13701087609, issue=Issue{id=1236369011668210230, tenantId=1146029695717560320, journalId=1235980733773295621, year='2023', volume='32', issue='15', pageStart='1489', pageEnd='1592', issueExtLink='null', onlineDate='null', pubDate='null', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1772702943007, creator=13701087609, updateTime=1772703232203, updator=13701087609, preIssue=null, nextIssue=null, ext={EN=IssueExt(id=1236370224711258643, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1236369011668210230, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1236370224711258644, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1236369011668210230, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null}, startPage=1585, endPage=1592, ext={EN=ArticleExt(id=1236369018026775274, articleId=1236369017783505623, tenantId=1146029695717560320, journalId=1235980733773295621, language=EN, title=Literature review and analysis of adverse drug reactions of brentuximab vedotin, columnId=null, journalTitle=Chinese Journal of New Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=
Objective:

To analyze the situation and clinical characteristics of adverse drug reactions induced by brentuximab vedotin, so as to provide reference for clinical safe and rational drug use.

Methods:

By searching the literature in CNKI, Wanfang, database, VIP, CBM, Embase, and PubMed, the adverse drug reaction cases after the marketing of brentuximab vedotin were collected and statistically analyzed.

Results:

A total of 24 literatures were involved and 254 patients were included. Adverse drug reactions induced by brentuximab vedotin mainly involved nervous system damage (30.13%), blood system damage (26.50%), immune dysfunction (9.62%), skin and subcutaneous tissue disorders (8.97%), systemic reaction (8.33%), with the specific performance of peripheral neuropathy, neutropenia, infections, infusion reaction, elevated transaminase levels, thrombocytopenia, rashes, and so on. Most of the patients with adverse reactions had good prognosis. Nine cases of death were reported, including interstitial lung disease (n=3), pneumonia (n=2), progressive multifocal leukoencephalopathy (n=2), heart failure (n=1) and acute liver injury (n=1).

Conclusion:

The doctors and pharmacists should pay attention to the adverse drug reactions by brentuximab vedotin. The adverse drug reaction monitoring should be strengthened, with the adverse drug reactions detected and dealt in time, so as to ensure the medication safety of patients.

, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, authorCompany=null, fund=null, authors=null, authorsList=Man LÜ, Jing CHEN, Zhe CHEN), CN=ArticleExt(id=1236369018353931004, articleId=1236369017783505623, tenantId=1146029695717560320, journalId=1235980733773295621, language=CN, title=维布妥昔单抗上市后不良反应文献回顾性分析, columnId=1236331163573342670, journalTitle=中国新药杂志, columnName=药物安全与合理应用, runingTitle=null, highlight=null, articleAbstract=
目的:

探讨维布妥昔单抗所致不良反应(ADR)的发生规律和临床表现特点,为其临床安全、合理用药提供参考。

方法:

检索中国知网、万方数据、维普网、中国生物医学文献数据库、Embase、PubMed数据库,收集上市后维布妥昔单抗致ADR的报道并进行统计分析。

结果:

共纳入文献24篇,涉及患者254例,所致ADR包括神经系统损害(30.13%)、血液系统损害(26.50%)、免疫功能紊乱(9.62%)、皮肤及附件损害(8.97%)、全身性损害(8.33%)等,其中以周围神经病变(29.70%)和中性粒细胞减少(21.37%)最为常见,其次为感染、输液反应、转氨酶升高、血小板减少、皮疹等。大部分患者经停药或减量后好转或痊愈,有9例患者因ADR而死亡,包括间质性肺病(3例)、肺炎(2例)、进行性多灶性白质脑病(2例)、心力衰竭(1例)、急性肝损伤(1例)。

结论:

临床医生、药师应重视维布妥昔单抗致ADR的危害性,临床使用中应加强对患者的监护,及时发现ADR并积极处理,确保患者用药安全。

, correspAuthors=null, authorNote=null, correspAuthorsNote=
陈喆,女,副主任药师,研究方向:临床药学。E-mail:
, copyrightStatement=null, copyrightOwner=《中国新药杂志》有限公司, extLink=null, articleAbsUrl=null, sourceXml=wFf6xC/v0lOf1msEtU0UfQ==, magXml=q0+g4GaTwAbhPSVmpYLyPw==, pdfUrl=null, pdf=PR4XIeWvkKKTeDfb9OPFCw==, pdfFileSize=1506078, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=ashqYJU44S0mJpg6ALaRQQ==, mapNumber=null, authorCompany=null, fund=null, authors=

吕曼,女,药师,研究方向:临床药学。E-mail:

, authorsList=吕曼, 陈静, 陈喆)}, authors=[Author(id=1236369018857247528, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=lyumans@163.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1236369018987270964, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, authorId=1236369018857247528, language=EN, stringName=Man LÜ, firstName=Man, middleName=null, lastName=LÜ, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1Department of Pharmacy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
2Department of Clinical Pharmacy, Sichuan Mental Health Center/The Third Hospital of Mianyang, Mianyang 621000, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1236369019096322877, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, authorId=1236369018857247528, language=CN, stringName=吕曼, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院药剂科,北京 100021
2四川省精神卫生中心/绵阳市第三人民医院临床药学科,绵阳 621000, bio={"content":"

吕曼,女,药师,研究方向:临床药学。E-mail:

"}, bioImg=null, bioContent=

吕曼,女,药师,研究方向:临床药学。E-mail:

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1236369018601394957, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, xref=1, ext=[AuthorCompanyExt(id=1236369018609783567, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, companyId=1236369018601394957, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1Department of Pharmacy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China), AuthorCompanyExt(id=1236369018618172176, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, companyId=1236369018601394957, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院药剂科,北京 100021)]), AuthorCompany(id=1236369018702058265, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, xref=2, ext=[AuthorCompanyExt(id=1236369018714641179, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, companyId=1236369018702058265, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2Department of Clinical Pharmacy, Sichuan Mental Health Center/The Third Hospital of Mianyang, Mianyang 621000, China), AuthorCompanyExt(id=1236369018723029789, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, companyId=1236369018702058265, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2四川省精神卫生中心/绵阳市第三人民医院临床药学科,绵阳 621000)])]), Author(id=1236369019192791876, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1236369019335398225, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, authorId=1236369019192791876, language=EN, stringName=Jing CHEN, firstName=Jing, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2Department of Clinical Pharmacy, Sichuan Mental Health Center/The Third Hospital of Mianyang, Mianyang 621000, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1236369019423478619, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, authorId=1236369019192791876, language=CN, stringName=陈静, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2四川省精神卫生中心/绵阳市第三人民医院临床药学科,绵阳 621000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1236369018702058265, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, xref=2, ext=[AuthorCompanyExt(id=1236369018714641179, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, companyId=1236369018702058265, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2Department of Clinical Pharmacy, Sichuan Mental Health Center/The Third Hospital of Mianyang, Mianyang 621000, China), AuthorCompanyExt(id=1236369018723029789, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, companyId=1236369018702058265, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2四川省精神卫生中心/绵阳市第三人民医院临床药学科,绵阳 621000)])]), Author(id=1236369019540919145, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=gigichen79@126.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1236369019645776757, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, authorId=1236369019540919145, language=EN, stringName=Zhe CHEN, firstName=Zhe, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1Department of Pharmacy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1236369019821937536, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, authorId=1236369019540919145, language=CN, stringName=陈喆, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院药剂科,北京 100021, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1236369018601394957, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, xref=1, ext=[AuthorCompanyExt(id=1236369018609783567, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, companyId=1236369018601394957, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1Department of Pharmacy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China), AuthorCompanyExt(id=1236369018618172176, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, companyId=1236369018601394957, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院药剂科,北京 100021)])])], keywords=[Keyword(id=1236369019998098320, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, language=EN, orderNo=1, keyword=brentuximab vedotin), Keyword(id=1236369020123927449, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, language=EN, orderNo=2, keyword=adverse drug reaction), Keyword(id=1236369020245562282, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, language=EN, orderNo=3, keyword=literature analysis), Keyword(id=1236369020388168629, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, language=CN, orderNo=1, keyword=维布妥昔单抗), Keyword(id=1236369020560135113, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, language=CN, orderNo=2, keyword=药品不良反应), Keyword(id=1236369020702741463, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, language=CN, orderNo=3, keyword=文献分析)], refs=null, funds=null, companyList=[AuthorCompany(id=1236369018601394957, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, xref=1, ext=[AuthorCompanyExt(id=1236369018609783567, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, companyId=1236369018601394957, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1Department of Pharmacy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China), AuthorCompanyExt(id=1236369018618172176, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, companyId=1236369018601394957, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院药剂科,北京 100021)]), AuthorCompany(id=1236369018702058265, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, xref=2, ext=[AuthorCompanyExt(id=1236369018714641179, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, companyId=1236369018702058265, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2Department of Clinical Pharmacy, Sichuan Mental Health Center/The Third Hospital of Mianyang, Mianyang 621000, China), AuthorCompanyExt(id=1236369018723029789, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369017783505623, companyId=1236369018702058265, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2四川省精神卫生中心/绵阳市第三人民医院临床药学科,绵阳 621000)])], figs=null, attaches=null, journal=Journal(id=1235980159023624194, delFlag=0, nameCn=中国新药杂志, nameEn=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, issn=1003-3734, eissn=null, cn=11-2850/R, coden=ZXZHA6, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of New Drugs, journalRemark=null, publicationField=null, createdTime=1772610233314, updatedTime=1772610649152, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=C, firstLetterEn=C, subjectCode=Life Sciences, subjectName=null, subjectCodeEn=Life Sciences, subjectNameEn=null, picCn=ohPEEN//Vz1tDT3ZBNTp4Q==, picEn=f9WK9bvTM4guTmS/iGhOMg==, jcr=null, cjcr=null, exts=[JournalExt(id=1235981903275290962, language=CN, name=中国新药杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1772610649174, updatedTime=1772610649174, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1235981903338205523, language=EN, name=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1772610649189, updatedTime=1772610649189, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1235980733773295621, websiteList=[Website(id=1235982099191222761, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/CN, language=CN, createTime=1772610695884, createBy=18614031015, updateTime=1772610860397, updateBy=18614031015, name=中国新药杂志-中文, tplId=1146099689490845704, title=中国新药杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983918629966444, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=articleTextType, value=kx, createTime=1772611129672, updateTime=1772611129672, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918604800617, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=banner, value=null, createTime=1772611129666, updateTime=1772611129666, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918655132271, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=grayFlag, value=0, createTime=1772611129678, updateTime=1772611129678, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918596412008, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611129664, updateTime=1772611129664, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918667715185, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=minRunFlag, value=0, createTime=1772611129681, updateTime=1772611129681, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918617383531, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic, createTime=1772611129669, updateTime=1772611129669, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918659326576, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=silenceFlag, value=0, createTime=1772611129679, updateTime=1772611129679, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918613189226, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1772611129668, updateTime=1772611129668, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918634160749, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeColor, value=null, createTime=1772611129673, updateTime=1772611129673, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918646743662, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeStyle, value=null, createTime=1772611129676, updateTime=1772611129676, creator=18614031015, updator=18614031015)]), Website(id=1235982099270914542, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/EN, language=EN, createTime=1772610695903, createBy=18614031015, updateTime=1772610875891, updateBy=18614031015, name=中国新药杂志-英文, tplId=1146101810881728533, title=Chinese Journal of New Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983955829248630, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=articleTextType, value=kx, createTime=1772611138541, updateTime=1772611138541, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955804082803, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=banner, value=null, createTime=1772611138535, updateTime=1772611138535, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955854414457, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=grayFlag, value=0, createTime=1772611138547, updateTime=1772611138547, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955795694194, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611138533, updateTime=1772611138533, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955866997371, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=minRunFlag, value=0, createTime=1772611138550, updateTime=1772611138550, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955820860021, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic, createTime=1772611138539, updateTime=1772611138539, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955862803066, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=silenceFlag, value=0, createTime=1772611138549, updateTime=1772611138549, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955812471412, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1772611138537, updateTime=1772611138537, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955837637239, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeColor, value=null, createTime=1772611138543, updateTime=1772611138543, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955846025848, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeStyle, value=null, createTime=1772611138545, updateTime=1772611138545, creator=18614031015, updator=18614031015)])], journalTitle=中国新药杂志, weixinUrl=null, journalUrl=http://www.newdrug.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of New Drugs, journalPhotoCn=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPhotoEn=f9WK9bvTM4guTmS/iGhOMg==, journalFirstLetter=C, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/Y2023/V32/I15/1585, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/Y2023/V32/I15/1585, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/PDF/Y2023/V32/I15/1585, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/PDF/Y2023/V32/I15/1585, aliStartDate=null, aliEndDate=null, collectionFlag=false, citedCount=null, citedUrl=null, reference=null)
收藏切换
维布妥昔单抗上市后不良反应文献回顾性分析
收藏切换
PDF下载
吕曼 1, 2 , 陈静 2 , 陈喆 1
中国新药杂志 | 药物安全与合理应用 2023,32(15): 1585-1592
收起
收藏切换
中国新药杂志 | 药物安全与合理应用 2023, 32(15): 1585-1592
维布妥昔单抗上市后不良反应文献回顾性分析
全屏
吕曼1, 2 , 陈静2, 陈喆1
作者信息
  • 1国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院药剂科,北京 100021
  • 2四川省精神卫生中心/绵阳市第三人民医院临床药学科,绵阳 621000
  • 吕曼,女,药师,研究方向:临床药学。E-mail:

通讯作者:

陈喆,女,副主任药师,研究方向:临床药学。E-mail:
Literature review and analysis of adverse drug reactions of brentuximab vedotin
Man LÜ1, 2 , Jing CHEN2, Zhe CHEN1
Affiliations
  • 1Department of Pharmacy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  • 2Department of Clinical Pharmacy, Sichuan Mental Health Center/The Third Hospital of Mianyang, Mianyang 621000, China
出版时间: 2023-08-15
文章导航
收藏切换
目的:

探讨维布妥昔单抗所致不良反应(ADR)的发生规律和临床表现特点,为其临床安全、合理用药提供参考。

方法:

检索中国知网、万方数据、维普网、中国生物医学文献数据库、Embase、PubMed数据库,收集上市后维布妥昔单抗致ADR的报道并进行统计分析。

结果:

共纳入文献24篇,涉及患者254例,所致ADR包括神经系统损害(30.13%)、血液系统损害(26.50%)、免疫功能紊乱(9.62%)、皮肤及附件损害(8.97%)、全身性损害(8.33%)等,其中以周围神经病变(29.70%)和中性粒细胞减少(21.37%)最为常见,其次为感染、输液反应、转氨酶升高、血小板减少、皮疹等。大部分患者经停药或减量后好转或痊愈,有9例患者因ADR而死亡,包括间质性肺病(3例)、肺炎(2例)、进行性多灶性白质脑病(2例)、心力衰竭(1例)、急性肝损伤(1例)。

结论:

临床医生、药师应重视维布妥昔单抗致ADR的危害性,临床使用中应加强对患者的监护,及时发现ADR并积极处理,确保患者用药安全。

维布妥昔单抗  /  药品不良反应  /  文献分析
Objective:

To analyze the situation and clinical characteristics of adverse drug reactions induced by brentuximab vedotin, so as to provide reference for clinical safe and rational drug use.

Methods:

By searching the literature in CNKI, Wanfang, database, VIP, CBM, Embase, and PubMed, the adverse drug reaction cases after the marketing of brentuximab vedotin were collected and statistically analyzed.

Results:

A total of 24 literatures were involved and 254 patients were included. Adverse drug reactions induced by brentuximab vedotin mainly involved nervous system damage (30.13%), blood system damage (26.50%), immune dysfunction (9.62%), skin and subcutaneous tissue disorders (8.97%), systemic reaction (8.33%), with the specific performance of peripheral neuropathy, neutropenia, infections, infusion reaction, elevated transaminase levels, thrombocytopenia, rashes, and so on. Most of the patients with adverse reactions had good prognosis. Nine cases of death were reported, including interstitial lung disease (n=3), pneumonia (n=2), progressive multifocal leukoencephalopathy (n=2), heart failure (n=1) and acute liver injury (n=1).

Conclusion:

The doctors and pharmacists should pay attention to the adverse drug reactions by brentuximab vedotin. The adverse drug reaction monitoring should be strengthened, with the adverse drug reactions detected and dealt in time, so as to ensure the medication safety of patients.

brentuximab vedotin  /  adverse drug reaction  /  literature analysis
吕曼, 陈静, 陈喆. 维布妥昔单抗上市后不良反应文献回顾性分析. 中国新药杂志, 2023 , 32 (15) : 1585 -1592 .
Man LÜ, Jing CHEN, Zhe CHEN. Literature review and analysis of adverse drug reactions of brentuximab vedotin[J]. Chinese Journal of New Drugs, 2023 , 32 (15) : 1585 -1592 .
2023年第32卷第15期
PDF下载
34
9
引用本文
BibTeX
文章信息
  • 首发时间:2026-03-05
  • 出版时间:2023-08-15
补充材料
相关文章
文章信息
作者
出版历史
  • 录用日期:2022-10-11
基金
作者信息
    1国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院药剂科,北京 100021
    2四川省精神卫生中心/绵阳市第三人民医院临床药学科,绵阳 621000

通讯作者:

陈喆,女,副主任药师,研究方向:临床药学。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgxyzz/CN/1236369017783505623
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏